Journal article

Recalibrating the risks and benefits of lithium therapy

Michael Berk, Stephanie Cowdery, Lana Williams, Gin S Malhi

BRITISH JOURNAL OF PSYCHIATRY | ROYAL COLL PSYCHIATRISTS | Published : 2017

Abstract

Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.

University of Melbourne Researchers

Grants

Awarded by NHMRC Senior Principal Research Fellowship


Awarded by NHMRC Career Development Fellowship


Funding Acknowledgements

This project was supported by a grant from Astra Zeneca. M.B is supported by an NHMRC Senior Principal Research Fellowship (No. 1059660). LW. is supported by an NHMRC Career Development Fellowship (GNT1064272).